Yahoo India Web Search

Search results

  1. Sep 16, 2024 · Pandorum - Developer of regenerative medicine and 3D tissues. Raised a total funding of $27.1M over 8 rounds from 60 investors. Valued at $48.3M. Founded by Tuhin Bhowmick and Arun Chandru in the year 2011. Pandorum has 128 competitors.

  2. 6 days ago · Pandorum has raised a total funding of $27.1M over 8 rounds from 60 investors. Investors include 500 Global, Kotak Investment Advisors and 58 others. Their latest funding round was of $11M on Aug 29, 2023 .

  3. Sep 1, 2024 · Pandorum has 128 competitors, of which 108 are active, 32 are funded and 10 have exited. Who are the newest competitors of Pandorum ? The newest competitor s of Pandorum are CONDUCTink , Omnipotent and Reju .

  4. Pandorum Technologies | 11,136 followers on LinkedIn. BUILDING BLOCKS OF LIFE | Pandorum is a biotechnology company based out of the US and India, working in the field of Tissue Engineering and...

  5. Mar 15, 2024 · Pandorum's Kuragenx promotes scarless regeneration of cornea tissue to restore vision, as demonstrated in extensive pre-clinical studies.

  6. Why Invest in Pandorum. Pandorum’s is the first in the country to design and 3D-print human liver tissues for medical research. The start-up is presently working on bio-engineered human cornea that can be implanted. Its 3D-printed human tissues can be used in medical research for drug metabolism and disease modelling.

  7. Mar 19, 2024 · Pandorum’s bioengineered cornea is a class of products powered by the company’s technology platforms—tissue regenerative exosomes and tissue-mimetic biomaterials, to be specific—in order to advance the potential regeneration of a healthy, functional cornea.

  8. People also ask